Skip to main content Skip to main menu
UF Health University of Florida

Department of Emergency Medicine

College of Medicine – Jacksonville

Make a Gift!
Faheem W Guirgis

Faheem W Guirgis, MD, FACEP

Associate Professor; Program Director, Emergency Medicine And Acute Care Research Fellowship

Department: Emergency Medicine – Jacksonville
Business Phone: (904) 244-4986
Business Email: faheem.guirgis@jax.ufl.edu
CV: View Curriculum Vitae

About Faheem W Guirgis

Dr. Faheem W. Guirgis, MD, FACEP is an Associate Professor of Emergency Medicine in the Department of Emergency Medicine at the University of Florida College of Medicine in Jacksonville. He received his medical degree from The Chicago Medical School at Rosalind Franklin University and his Emergency Medicine residency training at the Albert Einstein College of Medicine in the Bronx, NY. Dr. Guirgis’ clinical and research work focuses on sepsis, and more specifically on mechanisms of lipid dysregulation, clinical implications, and novel therapies. Dr. Guirgis has been the PI of numerous clinical trials and translational research projects in sepsis and critical care, including the LIPid Intensive Drug therapy for Sepsis-Pilot (LIPIDS-P) of his own design. He has a diverse portfolio of active research funding from NIH and other sources. Dr. Guirgis has been recognized for his role in the design of a novel Sepsis Alert Program implemented at UF Health Jacksonville which has led to improved outcomes in patients admitted with sepsis.

Board Certifications

  • Emergency Medicine
    American Board of Emergency Medicine

Clinical Profile

Specialties
  • Emergency Medicine

Research Profile

Dr. Guirgis’ clinical and research work focuses on sepsis, and more specifically on mechanisms of lipid dysregulation, clinical implications, and novel therapies. Dr. Guirgis has been the PI of numerous clinical trials and translational research projects in sepsis and critical care, including the LIPid Intensive Drug therapy for Sepsis-Pilot (LIPIDS-P) of his own design. He has a diverse portfolio of active research funding from NIH and other sources. Dr. Guirgis has been recognized for his role in the design of a novel Sepsis Alert Program implemented at UF Health Jacksonville which has led to improved outcomes in patients admitted with sepsis.

Open Researcher and Contributor ID (ORCID)

0000-0002-4445-3939

Publications

2020
Response to Editor letter “Admission characteristics predictive of in-hospital death from hospital-acquired sepsis: A comparison to community-acquired sepsis”.
Journal of Critical Care
2019
PCSK9 loss-of-function variants and risk of infection and sepsis in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort
PLoS One
2018
Effect of Levocarnitine vs Placebo as an Adjunctive Treatment for Septic Shock: The Rapid Administration of Carnitine in Sepsis (RACE) Randomized Clinical Trial
JAMA Network Open
2018
Hdl Cholesterol Efflux Is Impaired in Older Patients With Early Sepsis: a Subanalysis of a Prospective Pilot Study
Shock
2018
Hdl Inflammatory Index Correlates With and Predicts Severity of Organ Failure in Patients With Sepsis and Septic Shock
PLoS One
2018
Sequential Organ Failure Assessment Component Score Prediction of In-hospital Mortality From Sepsis.
Journal of Intensive Care Medicine
2017
Clinical Predictors of Early Death From Sepsis
Journal of Critical Care
2017
Development of a Simple Sequential Organ Failure Assessment Score for Risk Assessment of Emergency Department Patients With Sepsis
Journal of Intensive Care Medicine
2017
Exploring the Predictive Ability of Dysfunctional High-Density Lipoprotein for Adverse Outcomes in Emergency Department Patients With Sepsis: a Preliminary Investigation
Shock
2017
Managing sepsis: Electronic recognition, rapid response teams, and standardized care save lives
Journal of Critical Care
2017
Naloxone Triggering the RRT: A Human Antidote?
Journal of patient safety (Online)
2017
The Impact of the Sepsis-3 Septic Shock Definition on Previously Defined Septic Shock Patients
Critical Care Medicine
2016
Cholesterol Levels and Long-Term Rates of Community-Acquired Sepsis
Critical Care
2016
The Long-Term Burden of Severe Sepsis and Septic Shock: Sepsis Recidivism and Organ Dysfunction
Journal of Trauma and Acute Care Surgery
2016
Ultrasound-Guided Peripheral Intravenous Catheter Training Results in Physician-Level Success for Emergency Department Technicians
Journal of Ultrasound in Medicine
2016
End-Tidal Carbon Dioxide and Occult Injury in Trauma Patients Etco2 Does Not Rule Out Severe Injury
American Journal of Emergency Medicine
2015
The Bubble Study: Ultrasound Confirmation of Central Venous Catheter Placement
American Journal of Emergency Medicine
2015
The Relationship of Intravenous Fluid Chloride Content To Kidney Function in Patients With Severe Sepsis Or Septic Shock
American Journal of Emergency Medicine
2014
Carotid intima media thickness and low high-density lipoprotein (HDL) in South Asian immigrants: could dysfunctional HDL be the missing link?
Archives of Medical Science
2014
End-Tidal Carbon Dioxide as a Goal of Early Sepsis Therapy
American Journal of Emergency Medicine
2014
Long-Term Organ Dysfunction After Severe Sepsis
Critical Care Medicine
2013
Proactive Rounding By the Rapid Response Team Reduces Inpatient Cardiac Arrests
Resuscitation
2013
Rapid Discharge of Patients Presenting To the Emergency Department With Cocaine Chest Pain: Application of An Abbreviated Cardiac Enzyme Protocol in the Clinical Decision Unit
Annals of Emergency Medicine
2013
Successful Implementation of Proactive Rounding By a Rapid Response Team in a Tertiary, Academic, Level 1 Trauma Center Reduces Inpatient Cardiac Arrests and Facilitates Preemptive Transfer To a Higher Level of Care
Annals of Emergency Medicine

Grants

Jun 2020 ACTIVE
COVID:A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults
LEIDOS · Principal Investigator
Apr 2020 ACTIVE
COVID-19: Angiotensin Receptor blockers for novel SAR-CoV-2
UNIV OF MINNESOTA ·
Apr 2020 ACTIVE
The Role and Mechanisms of Lipid and Lipoprotein Dysregulation in Sepsis
NATL INST OF HLTH NIGMS · Principal Investigator
Jun 2018 ACTIVE
OR-DRPD-ROF2018: The LIPid Intensive Drug therapy for Sepsis Pilot (LIPIDS-P) Trial
UF RESEARCH · Principal Investigator
Jan 2018 – Dec 2019
Vitamin C, Thiamine and Steroids in Sepsis- multi-center, randomized, placebo-controlled, double-blind, adaptive clinical trial of vitamin C, thiamine and steroids as combination therapy in patients with sepsis.
JOHNS HOPKINS UNIV · Principal Investigator
Apr 2017 ACTIVE
HSC COM Matching Commitment
UNIV OF FLORIDA · Project Manager
Sep 2016 ACTIVE
The Role of Dysfunctional HDL in Sepsis
NATL INST OF HLTH NIGMS · Principal Investigator
Apr 2016 – Mar 2017
TOGETHER: TRANSFORMING AND TRANSLATING DISCOVERY TO IMPROVE ,HEALTH ,
NATL INST OF HLTH NCATS · Project Manager
Jan 2015 – Jan 2018
Dysfunctional HDL Vision
SOCIETY OF CRITICAL CARE MEDICINE · Principal Investigator
Mar 2014 – May 2018
Rapid Administration of Carnitine in Sepsis (RACE)
UNIV OF MISSISSIPPI · Principal Investigator

Education

Emergency Medicine Residency
2006-2010 · Albert Einstein College of Medicine, Bronx, New York
Doctor of Medicine
2002-2006 · Rosalind Franklin University, North Chicago, Illinois

Contact Details

Phones:
Business:
(904) 244-4986
Emails:
Business:
faheem.guirgis@jax.ufl.edu
Executive Assistant – EM Research:
Profile photo for Amy R Kennedy
Amy R Kennedy
Phone:
(904) 244-4986
View Profile